AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy
Completed
- Conditions
- Locally Advanced or Metastatic NSCLC
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 300
- Registration Number
- NCT04207775
- Locations
- 🇨🇳
Research Site, Zhuji, China
Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.
Phase 1
Terminated
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 25
- Registration Number
- NCT04199598
- Locations
- 🇩🇪
Research Site, Berlin, Germany
Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled Asthma
Completed
- Conditions
- Severe Uncontrolled Asthma
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 5
- Registration Number
- NCT04200326
A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy Volunteers
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 64
- Registration Number
- NCT04198558
- Locations
- 🇩🇪
Research Site, Berlin, Germany
A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
Phase 3
Active, not recruiting
- Conditions
- Hypereosinophilic Syndrome
- Interventions
- Biological: Placebo
- First Posted Date
- 2019-12-09
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 117
- Registration Number
- NCT04191304
- Locations
- 🇬🇧
Research Site, London, United Kingdom
A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen
Phase 2
Withdrawn
- Conditions
- Asthma
- Interventions
- Drug: AZD8154 nebulizer suspension, 20 mg/mLDrug: Placebo
- First Posted Date
- 2019-12-05
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT04187508
- Locations
- 🇨🇦
Research Site, Saskatoon, Saskatchewan, Canada
A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body
- First Posted Date
- 2019-12-05
- Last Posted Date
- 2021-08-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 14
- Registration Number
- NCT04187456
- Locations
- 🇺🇸
Research Site, Baltimore, Maryland, United States
Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions
Completed
- Conditions
- Asthma
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 246
- Registration Number
- NCT04184284
- Locations
- 🇩🇪
Research Site, Witten, Germany
A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 16
- Registration Number
- NCT04179071
- Locations
- 🇺🇸
Research Site, Baltimore, Maryland, United States
A Phase 2b Diabetic Kidney Disease Study
Phase 2
Completed
- Conditions
- Diabetic Kidney Disease
- Interventions
- First Posted Date
- 2019-11-20
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 609
- Registration Number
- NCT04170543
- Locations
- 🇵🇪
Research Site, Piura, Peru
© Copyright 2025. All Rights Reserved by MedPath